1. Home
  2. ALKS vs FCN Comparison

ALKS vs FCN Comparison

Compare ALKS & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • FCN
  • Stock Information
  • Founded
  • ALKS 1987
  • FCN 1982
  • Country
  • ALKS Ireland
  • FCN United States
  • Employees
  • ALKS N/A
  • FCN N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • FCN Professional Services
  • Sector
  • ALKS Health Care
  • FCN Consumer Discretionary
  • Exchange
  • ALKS Nasdaq
  • FCN Nasdaq
  • Market Cap
  • ALKS 4.9B
  • FCN 5.5B
  • IPO Year
  • ALKS 1991
  • FCN 1996
  • Fundamental
  • Price
  • ALKS $27.87
  • FCN $163.00
  • Analyst Decision
  • ALKS Strong Buy
  • FCN Hold
  • Analyst Count
  • ALKS 14
  • FCN 2
  • Target Price
  • ALKS $41.29
  • FCN $175.50
  • AVG Volume (30 Days)
  • ALKS 1.9M
  • FCN 252.1K
  • Earning Date
  • ALKS 10-23-2025
  • FCN 10-23-2025
  • Dividend Yield
  • ALKS N/A
  • FCN N/A
  • EPS Growth
  • ALKS 21.99
  • FCN N/A
  • EPS
  • ALKS 2.08
  • FCN 7.09
  • Revenue
  • ALKS $1,505,296,000.00
  • FCN $3,662,887,000.00
  • Revenue This Year
  • ALKS N/A
  • FCN $1.42
  • Revenue Next Year
  • ALKS $1.66
  • FCN $6.21
  • P/E Ratio
  • ALKS $13.19
  • FCN $23.23
  • Revenue Growth
  • ALKS N/A
  • FCN N/A
  • 52 Week Low
  • ALKS $25.17
  • FCN $151.75
  • 52 Week High
  • ALKS $36.45
  • FCN $231.65
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 48.33
  • FCN 42.37
  • Support Level
  • ALKS $26.40
  • FCN $161.95
  • Resistance Level
  • ALKS $28.65
  • FCN $167.23
  • Average True Range (ATR)
  • ALKS 1.13
  • FCN 3.19
  • MACD
  • ALKS -0.20
  • FCN -0.57
  • Stochastic Oscillator
  • ALKS 41.41
  • FCN 28.23

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: